Nobiletin exhibits circadian clock regulation and anti-obesity effects, and shows agonistic action at retinoic acid receptor-related orphan receptors (RORs) α and γ, with a higher affinity for RORγ [8]. The gene discussed is CLOCK; the disease is obesity disorder.